<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Thu, 30 May 2024 10:10:16 +0000</lastbuilddate>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>A distinct platelet differentiation pathway is involved in age-related thrombocytosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811855/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 May 29. doi: 10.1038/s41569-024-01043-9. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811855/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811855</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01043-9>10.1038/s41569-024-01043-9</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811855</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Karina Huynh</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>A distinct platelet differentiation pathway is involved in age-related thrombocytosis</dc:title>
<dc:identifier>pmid:38811855</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01043-9</dc:identifier>
</item>
<item>
<title>Reply: Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811100/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):e219. doi: 10.1016/j.jacc.2024.03.418.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811100/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811100</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.418>10.1016/j.jacc.2024.03.418</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811100</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Bjorn Redfors</dc:creator>
<dc:creator>Mario F L Gaudino</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part</dc:title>
<dc:identifier>pmid:38811100</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.418</dc:identifier>
</item>
<item>
<title>Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811099/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):e217. doi: 10.1016/j.jacc.2024.02.057.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811099/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811099</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.057>10.1016/j.jacc.2024.02.057</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811099</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Roberto Muniz Ferreira</dc:creator>
<dc:creator>Lúcia Helena Alvares Salis</dc:creator>
<dc:creator>Nelson Albuquerque de Souza E Silva</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part</dc:title>
<dc:identifier>pmid:38811099</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.057</dc:identifier>
</item>
<item>
<title>Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811098/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>Arrhythmias frequently accompany heart failure and left ventricular dysfunction. Tachycardias, atrial fibrillation, and premature ventricular contractions can induce a reversible form of dilated cardiomyopathy (CM) known as arrhythmia-induced CM (AiCM). The intriguing question is why certain individuals are more susceptible to AiCM, despite similar arrhythmia burdens. The primary challenge is determining the extent of arrhythmias' contribution to left ventricular systolic dysfunction. AiCM...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2214-2232. doi: 10.1016/j.jacc.2024.03.416.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Arrhythmias frequently accompany heart failure and left ventricular dysfunction. Tachycardias, atrial fibrillation, and premature ventricular contractions can induce a reversible form of dilated cardiomyopathy (CM) known as arrhythmia-induced CM (AiCM). The intriguing question is why certain individuals are more susceptible to AiCM, despite similar arrhythmia burdens. The primary challenge is determining the extent of arrhythmias' contribution to left ventricular systolic dysfunction. AiCM should be considered in patients with a mean heart rate of >;100 beats/min, atrial fibrillation, or a PVC burden of >;10%. Confirmation of AiCM occurs when CM reverses upon eliminating the responsible arrhythmia. Therapy choice depends on the specific arrhythmia, patient comorbidities, and preferences. After left ventricular function is restored, ongoing follow-up is essential if an abnormal myocardial substrate persists. Accurate diagnosis and treatment of AiCM have the potential to enhance patients' quality of life, improve clinical outcomes, and reduce hospital admissions and overall health care costs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811098/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811098</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.416>10.1016/j.jacc.2024.03.416</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811098</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Pouria Shoureshi</dc:creator>
<dc:creator>Alex Y Tan</dc:creator>
<dc:creator>Jayanthi Koneru</dc:creator>
<dc:creator>Kenneth A Ellenbogen</dc:creator>
<dc:creator>Karoly Kaszala</dc:creator>
<dc:creator>Jose F Huizar</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review</dc:title>
<dc:identifier>pmid:38811098</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.416</dc:identifier>
</item>
<item>
<title>Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>Despite impressive improvements in the care of patients with ST-segment elevation myocardial infarction, mortality remains high. Reperfusion is necessary for myocardial salvage, but the abrupt return of flow sets off a cascade of injurious processes that can lead to further necrosis. This has been termed myocardial ischemia-reperfusion injury and is the subject of this review. The pathologic and molecular bases for myocardial ischemia-reperfusion injury are increasingly understood and include...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2196-2213. doi: 10.1016/j.jacc.2024.02.056.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Despite impressive improvements in the care of patients with ST-segment elevation myocardial infarction, mortality remains high. Reperfusion is necessary for myocardial salvage, but the abrupt return of flow sets off a cascade of injurious processes that can lead to further necrosis. This has been termed myocardial ischemia-reperfusion injury and is the subject of this review. The pathologic and molecular bases for myocardial ischemia-reperfusion injury are increasingly understood and include injury from reactive oxygen species, inflammation, calcium overload, endothelial dysfunction, and impaired microvascular flow. A variety of pharmacologic strategies have been developed that have worked well in preclinical models and some have shown promise in the clinical setting. In addition, there are newer mechanical approaches including mechanical unloading of the heart prior to reperfusion that are in current clinical trials.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811097</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.02.056>10.1016/j.jacc.2024.02.056</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811097</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Frederick G P Welt</dc:creator>
<dc:creator>Wayne Batchelor</dc:creator>
<dc:creator>J Richard Spears</dc:creator>
<dc:creator>Claudia Penna</dc:creator>
<dc:creator>Pasquale Pagliaro</dc:creator>
<dc:creator>Borja Ibanez</dc:creator>
<dc:creator>Stavros G Drakos</dc:creator>
<dc:creator>George Dangas</dc:creator>
<dc:creator>Navin K Kapur</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement</dc:title>
<dc:identifier>pmid:38811097</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.02.056</dc:identifier>
</item>
<item>
<title>Transcatheter Superior Sinus Venosus Defect Closure: Experience Increases Patient Eligibility</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811096/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2193-2195. doi: 10.1016/j.jacc.2024.04.017.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811096/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811096</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.04.017>10.1016/j.jacc.2024.04.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811096</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Ryan Callahan</dc:creator>
<dc:creator>Matthew J Gillespie</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Transcatheter Superior Sinus Venosus Defect Closure: Experience Increases Patient Eligibility</dc:title>
<dc:identifier>pmid:38811096</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.04.017</dc:identifier>
</item>
<item>
<title>Transcatheter Covered Stent Exclusion of Superior Sinus Venosus Defects</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811095/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Procedural success was 97%. Recent modifications increased patient inclusions, decreased complications, and simplified the intervention.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2179-2192. doi: 10.1016/j.jacc.2024.03.417.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Transcatheter correction of sinus venosus defects (SVDs) using balloon-mounted covered stents provides an attractive surgical alternative. Surgery may be complicated by superior vena caval or right upper pulmonary vein (RUPV) stenosis, sinus nodal dysfunction, and residual additional pulmonary veins.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: Being a new intervention, technical modifications would simplify the procedure, improve universal applicability, and reduce or tackle complications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients were included if balloon interrogation of cavoatrial junction confirmed closure of SVD and redirected RUPV to the left atrium. A single-center experience was analyzed to summarize the procedural modifications over 8 years. Transesophageal echocardiogram (TEE) on follow-up was done to identify residual shunt, RUPV flows, and stent thrombosis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 100 patients including 9 children with a median age of 35 years (range, 4-69 years) underwent SVD closure after balloon interrogation. Among 57 patients balloon interrogated in the first 5 years, 70% underwent transcatheter closure, with 2 failures. RUPV occlusion caused the exclusions. Inclusions improved to 94% among the subsequent 65 balloon interrogations when RUPV protection was implemented, with 1 failure. Stent embolization caused the 3 failures warranting surgery. Recent modifications included limited transesophageal echocardiogram without anesthesia, avoiding venovenous circuit, interrogation with semicompliant balloons, trans-septal RUPV protection, overlapping stents to permit additional vein drainage to superior vena cava and tackle embolizations. There were no deaths. Minor complications included stent embolizations stabilized in catheterization laboratory in 2 patients, left innominate vein jailing in 2 patients, insignificant residual flows, and nonocclusive asymptomatic stent thrombosis in 4 patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Procedural success was 97%. Recent modifications increased patient inclusions, decreased complications, and simplified the intervention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811095/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811095</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.417>10.1016/j.jacc.2024.03.417</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811095</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Pramod Sagar</dc:creator>
<dc:creator>Kothandam Sivakumar</dc:creator>
<dc:creator>Puthiyedath Thejaswi</dc:creator>
<dc:creator>Monica Rajendran</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Transcatheter Covered Stent Exclusion of Superior Sinus Venosus Defects</dc:title>
<dc:identifier>pmid:38811095</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.417</dc:identifier>
</item>
<item>
<title>Enhancing HDL Function to Prevent Atherothrombosis: Is it Time to Efflux the HDL Hypothesis?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811094/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2175-2178. doi: 10.1016/j.jacc.2024.04.015.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811094/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811094</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.04.015>10.1016/j.jacc.2024.04.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811094</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Aloke V Finn</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Enhancing HDL Function to Prevent Atherothrombosis: Is it Time to Efflux the HDL Hypothesis?</dc:title>
<dc:identifier>pmid:38811094</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.04.015</dc:identifier>
</item>
<item>
<title>Revisiting a "Paradigm" in Cardiovascular and Kidney Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811093/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2160-2162. doi: 10.1016/j.jacc.2024.04.018.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811093/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811093</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.04.018>10.1016/j.jacc.2024.04.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811093</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Glenn M Chertow</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Revisiting a "Paradigm" in Cardiovascular and Kidney Disease</dc:title>
<dc:identifier>pmid:38811093</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.04.018</dc:identifier>
</item>
<item>
<title>Rethinking Heart Attack Prevention: The Myth of the "Vulnerable Plaque" and Reality of Patient Risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811092/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2145-2147. doi: 10.1016/j.jacc.2024.04.007.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811092/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811092</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.04.007>10.1016/j.jacc.2024.04.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811092</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Zahi A Fayad</dc:creator>
<dc:creator>Philip M Robson</dc:creator>
<dc:creator>Valentin Fuster</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Rethinking Heart Attack Prevention: The Myth of the "Vulnerable Plaque" and Reality of Patient Risk</dc:title>
<dc:identifier>pmid:38811092</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.04.007</dc:identifier>
</item>
<item>
<title>Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38811091/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In patients with recent myocardial infarction and multivessel coronary artery disease, coronary atherosclerotic plaque activity prognosticates individual coronary arteries and patients at risk for myocardial infarction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Jun 4;83(22):2135-2144. doi: 10.1016/j.jacc.2024.03.419.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Total coronary atherosclerotic plaque activity across the entire coronary arterial tree is associated with patient-level clinical outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: We aimed to investigate whether vessel-level coronary atherosclerotic plaque activity is associated with vessel-level myocardial infarction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this secondary analysis of an international multicenter study of patients with recent myocardial infarction and multivessel coronary artery disease, we assessed vessel-level coronary atherosclerotic plaque activity using coronary <sup>18</sup>F-sodium fluoride positron emission tomography to identify vessel-level myocardial infarction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Increased <sup>18</sup>F-sodium fluoride uptake was found in 679 of 2,094 coronary arteries and 414 of 691 patients. Myocardial infarction occurred in 24 (4%) vessels with increased coronary atherosclerotic plaque activity and in 25 (2%) vessels without increased coronary atherosclerotic plaque activity (HR: 2.08; 95% CI: 1.16-3.72; P = 0.013). This association was not demonstrable in those treated with coronary revascularization (HR: 1.02; 95% CI: 0.47-2.25) but was notable in untreated vessels (HR: 3.86; 95% CI: 1.63-9.10; P<sub>interaction</sub> = 0.024). Increased coronary atherosclerotic plaque activity in multiple coronary arteries was associated with heightened patient-level risk of cardiac death or myocardial infarction (HR: 2.43; 95% CI: 1.37-4.30; P = 0.002) as well as first (HR: 2.19; 95% CI: 1.18-4.06; P = 0.013) and total (HR: 2.50; 95% CI: 1.42-4.39; P = 0.002) myocardial infarctions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In patients with recent myocardial infarction and multivessel coronary artery disease, coronary atherosclerotic plaque activity prognosticates individual coronary arteries and patients at risk for myocardial infarction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38811091/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38811091</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.419>10.1016/j.jacc.2024.03.419</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38811091</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Kang-Ling Wang</dc:creator>
<dc:creator>Craig Balmforth</dc:creator>
<dc:creator>Mohammed N Meah</dc:creator>
<dc:creator>Marwa Daghem</dc:creator>
<dc:creator>Alastair J Moss</dc:creator>
<dc:creator>Evangelos Tzolos</dc:creator>
<dc:creator>Jacek Kwiecinski</dc:creator>
<dc:creator>Patrycja Molek-Dziadosz</dc:creator>
<dc:creator>Neil Craig</dc:creator>
<dc:creator>Anda Bularga</dc:creator>
<dc:creator>Philip D Adamson</dc:creator>
<dc:creator>Dana K Dawson</dc:creator>
<dc:creator>Parthiban Arumugam</dc:creator>
<dc:creator>Nikant K Sabharwal</dc:creator>
<dc:creator>John P Greenwood</dc:creator>
<dc:creator>Jonathan N Townend</dc:creator>
<dc:creator>Patrick A Calvert</dc:creator>
<dc:creator>James H F Rudd</dc:creator>
<dc:creator>Johan W Verjans</dc:creator>
<dc:creator>Daniel S Berman</dc:creator>
<dc:creator>Piotr J Slomka</dc:creator>
<dc:creator>Damini Dey</dc:creator>
<dc:creator>Nicholas L Mills</dc:creator>
<dc:creator>Edwin J R van Beek</dc:creator>
<dc:creator>Michelle C Williams</dc:creator>
<dc:creator>Marc R Dweck</dc:creator>
<dc:creator>David E Newby</dc:creator>
<dc:creator>PRE(18)FFIR Study Investigators</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction</dc:title>
<dc:identifier>pmid:38811091</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.419</dc:identifier>
</item>
<item>
<title>A functional cellular framework for sex and estrous cycle-dependent gene expression and behavior</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810647/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 28:S0092-8674(24)00589-0. doi: 10.1016/j.cell.2024.05.045. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810647/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810647</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.045>10.1016/j.cell.2024.05.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810647</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Joseph R Knoedler</dc:creator>
<dc:creator>Sayaka Inoue</dc:creator>
<dc:creator>Daniel W Bayless</dc:creator>
<dc:creator>Taehong Yang</dc:creator>
<dc:creator>Adarsh Tantry</dc:creator>
<dc:creator>Chung-Ha Davis</dc:creator>
<dc:creator>Nicole Y Leung</dc:creator>
<dc:creator>Srinivas Parthasarathy</dc:creator>
<dc:creator>Grace Wang</dc:creator>
<dc:creator>Maricruz Alvarado</dc:creator>
<dc:creator>Abbas H Rizvi</dc:creator>
<dc:creator>Lief E Fenno</dc:creator>
<dc:creator>Charu Ramakrishnan</dc:creator>
<dc:creator>Karl Deisseroth</dc:creator>
<dc:creator>Nirao M Shah</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A functional cellular framework for sex and estrous cycle-dependent gene expression and behavior</dc:title>
<dc:identifier>pmid:38810647</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.045</dc:identifier>
</item>
<item>
<title>Structure-based discovery of CFTR potentiators and inhibitors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810646/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel whose loss of function leads to cystic fibrosis, whereas its hyperactivation leads to secretory diarrhea. Small molecules that improve CFTR folding (correctors) or function (potentiators) are clinically available. However, the only potentiator, ivacaftor, has suboptimal pharmacokinetics and inhibitors have yet to be clinically developed. Here, we combine molecular docking, electrophysiology, cryo-EM, and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23:S0092-8674(24)00472-0. doi: 10.1016/j.cell.2024.04.046. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel whose loss of function leads to cystic fibrosis, whereas its hyperactivation leads to secretory diarrhea. Small molecules that improve CFTR folding (correctors) or function (potentiators) are clinically available. However, the only potentiator, ivacaftor, has suboptimal pharmacokinetics and inhibitors have yet to be clinically developed. Here, we combine molecular docking, electrophysiology, cryo-EM, and medicinal chemistry to identify CFTR modulators. We docked ∼155 million molecules into the potentiator site on CFTR, synthesized 53 test ligands, and used structure-based optimization to identify candidate modulators. This approach uncovered mid-nanomolar potentiators, as well as inhibitors, that bind to the same allosteric site. These molecules represent potential leads for the development of more effective drugs for cystic fibrosis and secretory diarrhea, demonstrating the feasibility of large-scale docking for ion channel drug discovery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810646/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810646</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.046>10.1016/j.cell.2024.04.046</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810646</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Fangyu Liu</dc:creator>
<dc:creator>Anat Levit Kaplan</dc:creator>
<dc:creator>Jesper Levring</dc:creator>
<dc:creator>Jürgen Einsiedel</dc:creator>
<dc:creator>Stephanie Tiedt</dc:creator>
<dc:creator>Katharina Distler</dc:creator>
<dc:creator>Natalie S Omattage</dc:creator>
<dc:creator>Ivan S Kondratov</dc:creator>
<dc:creator>Yurii S Moroz</dc:creator>
<dc:creator>Harlan L Pietz</dc:creator>
<dc:creator>John J Irwin</dc:creator>
<dc:creator>Peter Gmeiner</dc:creator>
<dc:creator>Brian K Shoichet</dc:creator>
<dc:creator>Jue Chen</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Structure-based discovery of CFTR potentiators and inhibitors</dc:title>
<dc:identifier>pmid:38810646</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.046</dc:identifier>
</item>
<item>
<title>Reciprocal conversion between annual and polycarpic perennial flowering behavior in the Brassicaceae</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810645/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>The development of perennial crops holds great promise for sustainable agriculture and food security. However, the evolution of the transition between perenniality and annuality is poorly understood. Here, using two Brassicaceae species, Crucihimalaya himalaica and Erysimum nevadense, as polycarpic perennial models, we reveal that the transition from polycarpic perennial to biennial and annual flowering behavior is a continuum determined by the dosage of three closely related MADS-box genes....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 21:S0092-8674(24)00473-2. doi: 10.1016/j.cell.2024.04.047. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The development of perennial crops holds great promise for sustainable agriculture and food security. However, the evolution of the transition between perenniality and annuality is poorly understood. Here, using two Brassicaceae species, Crucihimalaya himalaica and Erysimum nevadense, as polycarpic perennial models, we reveal that the transition from polycarpic perennial to biennial and annual flowering behavior is a continuum determined by the dosage of three closely related MADS-box genes. Diversification of the expression patterns, functional strengths, and combinations of these genes endows species with the potential to adopt various life-history strategies. Remarkably, we find that a single gene among these three is sufficient to convert winter-annual or annual Brassicaceae plants into polycarpic perennial flowering plants. Our work delineates a genetic basis for the evolution of diverse life-history strategies in plants and lays the groundwork for the generation of diverse perennial Brassicaceae crops in the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810645/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810645</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.047>10.1016/j.cell.2024.04.047</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810645</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Dong Zhai</dc:creator>
<dc:creator>Lu-Yi Zhang</dc:creator>
<dc:creator>Ling-Zi Li</dc:creator>
<dc:creator>Zhou-Geng Xu</dc:creator>
<dc:creator>Xiao-Li Liu</dc:creator>
<dc:creator>Guan-Dong Shang</dc:creator>
<dc:creator>Bo Zhao</dc:creator>
<dc:creator>Jian Gao</dc:creator>
<dc:creator>Fu-Xiang Wang</dc:creator>
<dc:creator>Jia-Wei Wang</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Reciprocal conversion between annual and polycarpic perennial flowering behavior in the Brassicaceae</dc:title>
<dc:identifier>pmid:38810645</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.047</dc:identifier>
</item>
<item>
<title>Evolution of diapause in the African turquoise killifish by remodeling the ancient gene regulatory landscape</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810644/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>Suspended animation states allow organisms to survive extreme environments. The African turquoise killifish has evolved diapause as a form of suspended development to survive a complete drought. However, the mechanisms underlying the evolution of extreme survival states are unknown. To understand diapause evolution, we performed integrative multi-omics (gene expression, chromatin accessibility, and lipidomics) in the embryos of multiple killifish species. We find that diapause evolved by a...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23:S0092-8674(24)00474-4. doi: 10.1016/j.cell.2024.04.048. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Suspended animation states allow organisms to survive extreme environments. The African turquoise killifish has evolved diapause as a form of suspended development to survive a complete drought. However, the mechanisms underlying the evolution of extreme survival states are unknown. To understand diapause evolution, we performed integrative multi-omics (gene expression, chromatin accessibility, and lipidomics) in the embryos of multiple killifish species. We find that diapause evolved by a recent remodeling of regulatory elements at very ancient gene duplicates (paralogs) present in all vertebrates. CRISPR-Cas9-based perturbations identify the transcription factors REST/NRSF and FOXOs as critical for the diapause gene expression program, including genes involved in lipid metabolism. Indeed, diapause shows a distinct lipid profile, with an increase in triglycerides with very-long-chain fatty acids. Our work suggests a mechanism for the evolution of complex adaptations and offers strategies to promote long-term survival by activating suspended animation programs in other species.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810644/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810644</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.048>10.1016/j.cell.2024.04.048</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810644</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Param Priya Singh</dc:creator>
<dc:creator>G Adam Reeves</dc:creator>
<dc:creator>Kévin Contrepois</dc:creator>
<dc:creator>Katharina Papsdorf</dc:creator>
<dc:creator>Jason W Miklas</dc:creator>
<dc:creator>Mathew Ellenberger</dc:creator>
<dc:creator>Chi-Kuo Hu</dc:creator>
<dc:creator>Michael P Snyder</dc:creator>
<dc:creator>Anne Brunet</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Evolution of diapause in the African turquoise killifish by remodeling the ancient gene regulatory landscape</dc:title>
<dc:identifier>pmid:38810644</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.048</dc:identifier>
</item>
<item>
<title>A neural circuit for male sexual behavior and reward</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810643/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 28:S0092-8674(24)00591-9. doi: 10.1016/j.cell.2024.05.047. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810643/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810643</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.047>10.1016/j.cell.2024.05.047</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810643</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Daniel W Bayless</dc:creator>
<dc:creator>Chung-Ha O Davis</dc:creator>
<dc:creator>Renzhi Yang</dc:creator>
<dc:creator>Yichao Wei</dc:creator>
<dc:creator>Vinicius Miessler de Andrade Carvalho</dc:creator>
<dc:creator>Joseph R Knoedler</dc:creator>
<dc:creator>Taehong Yang</dc:creator>
<dc:creator>Oscar Livingston</dc:creator>
<dc:creator>Akira Lomvardas</dc:creator>
<dc:creator>Gabriela J Martins</dc:creator>
<dc:creator>Ana Mafalda Vicente</dc:creator>
<dc:creator>Jun B Ding</dc:creator>
<dc:creator>Liqun Luo</dc:creator>
<dc:creator>Nirao M Shah</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A neural circuit for male sexual behavior and reward</dc:title>
<dc:identifier>pmid:38810643</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.047</dc:identifier>
</item>
<item>
<title>Limbic Neurons Shape Sex Recognition and Social Behavior in Sexually Naive Males</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810642/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 28:S0092-8674(24)00587-7. doi: 10.1016/j.cell.2024.05.043. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810642/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810642</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.043>10.1016/j.cell.2024.05.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810642</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Daniel W Bayless</dc:creator>
<dc:creator>Taehong Yang</dc:creator>
<dc:creator>Matthew M Mason</dc:creator>
<dc:creator>Albert A T Susanto</dc:creator>
<dc:creator>Alexandra Lobdell</dc:creator>
<dc:creator>Nirao M Shah</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Limbic Neurons Shape Sex Recognition and Social Behavior in Sexually Naive Males</dc:title>
<dc:identifier>pmid:38810642</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.043</dc:identifier>
</item>
<item>
<title>Periodic Remodeling in a Neural Circuit Governs Timing of Female Sexual Behavior</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38810641/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 28:S0092-8674(24)00588-9. doi: 10.1016/j.cell.2024.05.044. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38810641/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38810641</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.044>10.1016/j.cell.2024.05.044</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38810641</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Sayaka Inoue</dc:creator>
<dc:creator>Renzhi Yang</dc:creator>
<dc:creator>Adarsh Tantry</dc:creator>
<dc:creator>Chung-Ha Davis</dc:creator>
<dc:creator>Taehong Yang</dc:creator>
<dc:creator>Joseph R Knoedler</dc:creator>
<dc:creator>Yichao Wei</dc:creator>
<dc:creator>Eliza L Adams</dc:creator>
<dc:creator>Shivani Thombare</dc:creator>
<dc:creator>Samantha R Golf</dc:creator>
<dc:creator>Rachael L Neve</dc:creator>
<dc:creator>Marc Tessier-Lavigne</dc:creator>
<dc:creator>Jun B Ding</dc:creator>
<dc:creator>Nirao M Shah</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Periodic Remodeling in a Neural Circuit Governs Timing of Female Sexual Behavior</dc:title>
<dc:identifier>pmid:38810641</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.044</dc:identifier>
</item>
<item>
<title>Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38809567/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: In this study, older adults with HF had substantial risk of kidney complications, with an estimated 6% progressing to dialysis in the year after HF hospitalization. These findings emphasize the need for health care approaches prioritizing kidney health in this high-risk population.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 29. doi: 10.1001/jamacardio.2024.1108. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Kidney health has received increasing focus as part of comprehensive heart failure (HF) treatment efforts. However, the occurrence of clinically relevant kidney outcomes in contemporary populations with HF has not been well studied.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To examine rates of incident dialysis and acute kidney injury (AKI) among Medicare beneficiaries after HF hospitalization.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study evaluated adults aged 65 years or older who were hospitalized for HF across 372 sites in the Get With The Guidelines-Heart Failure registry in the US between January 1, 2014, and December 31, 2018. Patients younger than 65 years or requiring dialysis either during or prior to hospitalization were excluded. Data were analyzed from May 4, 2021, to March 8, 2024.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary outcome was inpatient dialysis initiation in the year after HF hospitalization and was ascertained via linkage with Medicare claims data. Other all-cause and cause-specific hospitalizations were also evaluated. The covariate-adjusted association between discharge estimated glomerular filtration rate (eGFR) and 1-year postdischarge outcomes was examined using Cox proportional hazards regression models.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Overall, among 85 298 patients included in the analysis (mean [SD] age, 80 [9] years; 53% women) mean (SD) left ventricular ejection fraction was 47% (16%) and mean (SD) eGFR was 53 (29) mL/min per 1.73 m2; 54 010 (63%) had an eGFR less than 60 mL/min per 1.73 m2. By 1 year after HF hospitalization, 6% had progressed to dialysis, 7% had progressed to dialysis or end-stage kidney disease, and 7% had been readmitted for AKI. Incident dialysis increased steeply with lower discharge eGFR category: compared with patients with an eGFR of 60 mL/min per 1.73 m2 or more, individuals with an eGFR of 45 to less than 60 and of less than 30 mL/min per 1.73 m2 had higher rates of dialysis readmission (45 to &lt;60: adjusted hazard ratio [AHR], 2.16 [95% CI, 1.86-2.51]; &lt;30: AHR, 28.46 [95% CI, 25.25-32.08]). Lower discharge eGFR (per 10 mL/min per 1.73 m2 decrease) was independently associated with a higher rate of readmission for dialysis (AHR, 2.23; 95% CI, 2.14-2.32), dialysis or end-stage kidney disease (AHR, 2.34; 95% CI, 2.24-2.44), and AKI (AHR, 1.25; 95% CI, 1.23-1.27), with similar findings for all-cause mortality, all-cause readmission, and HF readmission. Baseline left ventricular ejection fraction did not modify the covariate-adjusted association between lower discharge eGFR and kidney outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: In this study, older adults with HF had substantial risk of kidney complications, with an estimated 6% progressing to dialysis in the year after HF hospitalization. These findings emphasize the need for health care approaches prioritizing kidney health in this high-risk population.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38809567/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38809567</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.1108>10.1001/jamacardio.2024.1108</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38809567</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>John W Ostrominski</dc:creator>
<dc:creator>Stephen J Greene</dc:creator>
<dc:creator>Ravi B Patel</dc:creator>
<dc:creator>Nicole C Solomon</dc:creator>
<dc:creator>Karen Chiswell</dc:creator>
<dc:creator>Adam D DeVore</dc:creator>
<dc:creator>Javed Butler</dc:creator>
<dc:creator>Paul A Heidenreich</dc:creator>
<dc:creator>Joanna C Huang</dc:creator>
<dc:creator>Michelle M Kittleson</dc:creator>
<dc:creator>Karen E Joynt Maddox</dc:creator>
<dc:creator>Karthik K Linganathan</dc:creator>
<dc:creator>James J McDermott</dc:creator>
<dc:creator>Anjali Tiku Owens</dc:creator>
<dc:creator>Pamela N Peterson</dc:creator>
<dc:creator>Scott D Solomon</dc:creator>
<dc:creator>Orly Vardeny</dc:creator>
<dc:creator>Clyde W Yancy</dc:creator>
<dc:creator>Gregg C Fonarow</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure</dc:title>
<dc:identifier>pmid:38809567</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.1108</dc:identifier>
</item>
<item>
<title>High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38809565/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: In this study, the proteins associated with risk of HF and frailty enrich for pathways related to inflammation and fibrosis as well as risk of HFpEF. Several of these proteins could potentially contribute to the shared pathophysiology of frailty and HF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 29. doi: 10.1001/jamacardio.2024.1178. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Heart failure (HF) and frailty frequently coexist and may share a common pathobiology, although the underlying mechanisms remain unclear. Understanding these mechanisms may provide guidance for preventing and treating both conditions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To identify shared pathways between incident HF and frailty in late life using large-scale proteomics.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, 4877 aptamers (Somascan v4) were measured among participants in the community-based longitudinal Atherosclerosis Risk In Communities (ARIC) cohort study at visit 3 (V3; 1993-1995; n = 10 638) and at visit 5 (V5; 2011-2013; n = 3908). Analyses were externally replicated among 3189 participants in the Cardiovascular Health Study (CHS). Data analysis was conducted from February 2022 to June 2023.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Protein aptamers, measured at study V3 and V5.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Outcomes assessed included incident HF hospitalization after V3 and after V5, prevalent frailty at V5, and incident frailty between V5 and visit 6 (V6; 2016-2017; n = 4131). Frailty was assessed using the Fried criteria. Analyses were adjusted for age, gender, race, field center, hypertension, diabetes, smoking status, body mass index, estimated glomerular filtration rate, prevalent coronary heart disease, prevalent atrial fibrillation, and history of myocardial infarction. Mendelian randomization (MR) analysis was performed to assess potential causal effects of candidate proteins on HF and frailty.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 4877 protein aptamers were measured among 10 638 participants at V3 (mean [SD] age, 60 [6] years; 4886 [46%] men). Overall, 286 proteins were associated with incident HF after V3 (822 events; P &lt; 1.0 × 10-5), 83 of which were also associated with incident after V5 (336 events; P &lt; 1.7 × 10-4). Among HF-free participants at V5 (n = 3908; mean [SD] age, 75 [5] years; 1861 [42%] men), 48 of 83 HF-associated proteins were associated with prevalent frailty (223 cases; P &lt; 6.0 × 10-4), 18 of which were also associated with incident frailty at V6 (152 cases; P &lt; 1.0 × 10-3). These proteins enriched fibrosis and inflammation pathways and demonstrated stronger associations with incident HF with preserved ejection fraction (HFpEF) than HF with reduced ejection fraction. All 18 proteins were associated with both prevalent frailty and incident HF in CHS. MR identified potential causal effects of several proteins on frailty and HF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: In this study, the proteins associated with risk of HF and frailty enrich for pathways related to inflammation and fibrosis as well as risk of HFpEF. Several of these proteins could potentially contribute to the shared pathophysiology of frailty and HF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38809565/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38809565</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.1178>10.1001/jamacardio.2024.1178</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38809565</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Diego Ramonfaur</dc:creator>
<dc:creator>Leo F Buckley</dc:creator>
<dc:creator>Victoria Arthur</dc:creator>
<dc:creator>Yimin Yang</dc:creator>
<dc:creator>Brian L Claggett</dc:creator>
<dc:creator>Chiadi E Ndumele</dc:creator>
<dc:creator>Keenan A Walker</dc:creator>
<dc:creator>Thomas Austin</dc:creator>
<dc:creator>Michelle C Odden</dc:creator>
<dc:creator>James S Floyd</dc:creator>
<dc:creator>Sandra Sanders-van Wijk</dc:creator>
<dc:creator>Joyce Njoroge</dc:creator>
<dc:creator>Jorge R Kizer</dc:creator>
<dc:creator>Dalane Kitzman</dc:creator>
<dc:creator>Suma H Konety</dc:creator>
<dc:creator>Jennifer Schrack</dc:creator>
<dc:creator>Fangyu Liu</dc:creator>
<dc:creator>B Gwen Windham</dc:creator>
<dc:creator>Priya Palta</dc:creator>
<dc:creator>Josef Coresh</dc:creator>
<dc:creator>Bing Yu</dc:creator>
<dc:creator>Amil M Shah</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life</dc:title>
<dc:identifier>pmid:38809565</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.1178</dc:identifier>
</item>
<item>
<title>Educational Attainment and Cardiovascular Risk-A Missed Opportunity?-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38809536/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240530061014&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 May 29. doi: 10.1001/jamacardio.2024.0818. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38809536/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240530061014&v=2.18.0.post9+e462414">38809536</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.0818>10.1001/jamacardio.2024.0818</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38809536</guid>
<pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Jared W Magnani</dc:creator>
<dc:creator>Norrina B Allen</dc:creator>
<dc:date>2024-05-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Educational Attainment and Cardiovascular Risk-A Missed Opportunity?-Reply</dc:title>
<dc:identifier>pmid:38809536</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.0818</dc:identifier>
</item>





























</channel>
</rss>